Perspective Therapeutics Inc. is an innovative biotechnology company specializing in the development of next-generation radiopharmaceuticals designed to treat various types of cancer. Utilizing cutting-edge radioisotope technologies, the company aims to enhance the efficacy of cancer treatments, thereby improving patient outcomes in a rapidly evolving market for targeted therapies. With a strong leadership team and strategic partnerships, Perspective Therapeutics is well-equipped to advance its mission and deliver breakthrough solutions that address the growing need for effective cancer interventions.

NYSE MKT

USA

HEALTHCARE

MEDICAL DEVICES

2401 ELLIOTT AVENUE, SEATTLE, WA, UNITED STATES, 98121

December

$509 Million

-$110 Million

0.0

-1.41

$0.00

0.0%

1.871